Patents by Inventor Mar Tormo

Mar Tormo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
    Patent number: 7285288
    Abstract: The present invention provides novel compositions and methods for use in the treatment of Bcl-2-associated diseases like cancer, specifically, in the treatment of follicular lymphoma (FL). The compositions contain antisense oligonucleotides that hybridize to Bcl-2 nucleic acids, the gene products of which are known to interact with the tumorigenic protein Bcl-2. Used alone, or in conjunction with other antisense oligonucleotides, these compositions inhibit the proliferation of FL cancer cells.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: October 23, 2007
    Assignee: Board of Regents, the University of Texas System
    Inventors: Mar Tormo, Ana M Tari, Gabriel Lopez-Berestein, Timothy J McDonnell
  • Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
    Patent number: 6977244
    Abstract: The present invention provides novel compositions and methods for use in the treatment of Bcl-2-associated diseases like cancer, specifically, in the treatment of follicular lymphoma (FL). The compositions contain antisense oligonucleotides that hybridize to Bcl-2 nucleic acids, the gene products of which are known to interact with the tumorigenic protein Bcl-2. Used alone, or in conjunction with other antisense oligonucleotides, these compositions inhibit the proliferation of FL cancer cells.
    Type: Grant
    Filed: October 4, 1996
    Date of Patent: December 20, 2005
    Assignee: Board of Regents, The University of Texas Systems
    Inventors: Mar Tormo, Ana M. Tari, Gabriel Lopez-Berestein
  • Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
    Publication number: 20030219474
    Abstract: The present invention provides novel compositions and methods for use in the treatment of Bcl-2-associated diseases like cancer, specifically, in the treatment of follicular lymphoma (FL). The compositions contain antisense oligonucleotides that hybridize to Bcl-2 nucleic acids, the gene products of which are known to interact with the tumorigenic protein Bcl-2. Used alone, or in conjunction with other antisense oligonucleotides, these compositions inhibit the proliferation of FL cancer cells.
    Type: Application
    Filed: March 12, 2003
    Publication date: November 27, 2003
    Inventors: Mar Tormo, Ana M. Tari, Gabriel Lopez-Berestein
  • INHIBITION OF BCL-2 PROTEIN EXPRESSION BY LIPOSOMAL ANTISENSE OLIGODEOXYNUCLEOTIDES
    Publication number: 20030012812
    Abstract: The present invention provides novel compositions and methods for use in the treatment of Bcl-2-associated diseases like cancer, specifically, in the treatment of follicular lymphoma (FL). The compositions contain antisense oligonucleotides that hybridize to Bcl-2 nucleic acids, the gene products of which are known to interact with the tumorigenic protein Bcl-2. Used alone, or in conjunction with other antisense oligonucleotides, these compositions inhibit the proliferation of FL cancer cells.
    Type: Application
    Filed: October 4, 1996
    Publication date: January 16, 2003
    Inventors: MAR TORMO, ANA M. TARI, GABRIEL LOPEZ-BERESTEIN